A study on heart pump therapy and stress echo for advanced heart failure
Part of Heart & circulation clinical trials.
This trial tests how well a heart stress ultrasound (dobutamine echo) can predict if you will get better from a special heart device called cardiac contractility modulation (CCM). CCM is a pacemaker-like implant for people with advanced heart failure who still have symptoms even with the best medicines. The study will help doctors know which patients benefit the most from this device.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have heart failure with symptoms even after trying the best medicines.
- Your heart's pumping strength is below 50% (low ejection fraction).
- You have already been told you might get a CCM device based on current guidelines.
- In the last year, you have been hospitalized, gone to the ER, or had at least one day visit for heart failure treatment that lasted over 4 hours (including IV heart medication).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a heart device (CCM) plus standard medications to see if the combination helps people with a weak heart pump. It's for those whose heart function is low and who still have symptoms despite current treatment.
This study tests a therapy called Cardiac Contractility Modulation (CCM) for people with heart failure. It uses a device to help the heart pump more strongly, and researchers compare it to standard care using patient records.
This study is testing a heart pump device for people with very advanced heart failure. It's for patients who are very sick and haven't improved with standard treatments. The study will see if this pump is safe and effective.
This study tests whether a heart-related device called CCM can improve symptoms and daily function in people with heart failure and a moderately reduced pumping strength. It may help if you’ve had recent heart-failure-related hospital care or urgent treatment and your heart and overall health fit the study limits.
This study tests a new heart scan method to help doctors place pacemakers more accurately for people with heart failure. It aims to improve the effectiveness of the pacemaker treatment and may lead to better outcomes for patients.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
Hear when a new Symptomatic Congestive Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.